Wondering if Humana is quietly turning into a value opportunity after a rough stretch, or if the stock is cheap for a reason?

Humana stock has experienced significant fluctuations in recent years, but has historically been able to bounce back after market downturns. However, in 2024, Humana has faced challenges due to rising ...

Humana (HUM) stock has remained sideways for the year with the company lowering its full-year earnings outlook. While Humana ...

Humana (HUM) has been on a choppy path lately, with the stock slipping over the past 3 months even as profits grow. That gap ...

Humana raised its 2025 guidance alongside the release of second quarter results that beat analyst expectations on Wednesday. It’s a bright spot for investors in the health insurance sector following ...

Humana (HUM) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

In early November 2025, Humana Inc. reported third quarter results showing increased revenue to US$32.65 billion, but net income dropped to US$195 million compared to the previous year. The company ...

Humana, the Louisville-based health insurer with an emphasis on Medicare Advantage plans, has announced its new CEO and president will assume the role effective July 1. Previously the company ...

Humana is a private insurance company that offers Medicare Advantage with Part D coverage and stand-alone Part D plans. Deductibles, monthly premiums, and drug copays depend on the specific plan.